Evidence map›Paper›PMID 34148386›Full record

ArticleJournal of investigative medicine high impact case reports

Atraumatic Splenic Rupture in a Patient on Apixaban and Dual Antiplatelet Therapy.

Piruthiviraj Natarajan, Sudhagar Thangarasu, Lela Ruck, Paul Estrada, Mahesh Gajendran, Gowri Renganathan, Bharat Ved Prakash, Olufemi Aduroja

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of investigative medicine high impact case reports. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. [Spontaneous splenic rupture. Case report and literature review].Revista medica del Instituto Mexicano del Seguro Social · 2023
    Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Piruthiviraj NatarajanTexas Tech University Health Sciences Center, El Paso, TX, USA.ORCID 0000-0003-2702-7476
Sudhagar ThangarasuTexas Tech University Health Sciences Center, El Paso, TX, USA.
Lela RuckTexas Tech University Health Sciences Center, El Paso, TX, USA.
Paul EstradaTexas Tech University Health Sciences Center, El Paso, TX, USA.
Mahesh GajendranTexas Tech University Health Sciences Center, El Paso, TX, USA.
Gowri RenganathanTexas Tech University Health Sciences Center, El Paso, TX, USA.
Bharat Ved PrakashTexas Tech University Health Sciences Center, El Paso, TX, USA.
Olufemi AdurojaTexas Tech University Health Sciences Center, El Paso, TX, USA.
Texas Tech University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Splenic rupture due to any cause is a life-threatening complication and commonly attributed to trauma. Atraumatic splenic rupture is very rarely reported, and the incidence is currently unknown. Anticoagulants and dual anti-platelet medication can increase the chances of a splenic rupture. Surgical removal of the spleen may be warranted to prevent a life-threatening bleeding. Early identification and intervention are required for most patients as only a few qualify for medical management.

Indexed as

Platelet Aggregation InhibitorsSplenic RuptureHumansPyrazolesPyridonesRupture, SpontaneousapixabanPlatelet Aggregation InhibitorsPyrazolesPyridonesapixabanatraumatic splenic rupturedual antiplatelet therapy

Identifiers

PMID34148386
PMCPMC8221677
OpenAlexW3175443147

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.